UBS Group’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $260K | Buy |
69,992
+15,231
| +28% | +$105K | ﹤0.01% | 6489 |
|
|
2025
Q4 | $448K | Sell |
54,761
-38,067
| -41% | -$282K | ﹤0.01% | 6159 |
|
|
2025
Q3 | $683K | Sell |
92,828
-3,823
| -4% | -$28.9K | ﹤0.01% | 5860 |
|
|
2025
Q2 | $785K | Sell |
96,651
-13,566
| -12% | -$91.5K | ﹤0.01% | 5643 |
|
|
2025
Q1 | $776K | Buy |
110,217
+1,236
| +1% | +$7.68K | ﹤0.01% | 5500 |
|
|
2024
Q4 | $810K | Buy |
108,981
+72,890
| +202% | +$466K | ﹤0.01% | 5475 |
|
|
2024
Q3 | $178K | Buy |
36,091
+2,232
| +7% | +$11.7K | ﹤0.01% | 5961 |
|
|
2024
Q2 | $174K | Buy |
33,859
+9,070
| +37% | +$53.7K | ﹤0.01% | 5763 |
|
|
2024
Q1 | $132K | Sell |
24,789
-50,975
| -67% | -$365K | ﹤0.01% | 6097 |
|
|
2023
Q4 | $469K | Sell |
75,764
-5,767
| -7% | -$40K | ﹤0.01% | 5158 |
|
|
2023
Q3 | $615K | Buy |
81,531
+76,531
| +1,531% | +$700K | ﹤0.01% | 4500 |
|
|
2023
Q2 | $48.4K | Sell |
5,000
-26,169
| -84% | -$160K | ﹤0.01% | 6496 |
|
|
2023
Q1 | $118K | Buy |
31,169
+1,667
| +6% | +$9.29K | ﹤0.01% | 5794 |
|
|
2022
Q4 | $191K | Buy |
29,502
+6,589
| +29% | +$54.3K | ﹤0.01% | 5494 |
|
|
2022
Q3 | $204K | Sell |
22,913
-197
| -0.9% | -$2K | ﹤0.01% | 5065 |
|
|
2022
Q2 | $231K | Sell |
23,110
-6,511
| -22% | -$64.5K | ﹤0.01% | 4800 |
|
|
2022
Q1 | $343K | Sell |
29,621
-17,590
| -37% | -$196K | ﹤0.01% | 4964 |
|
|
2021
Q4 | $524K | Buy |
47,211
+11,971
| +34% | +$116K | ﹤0.01% | 4939 |
|
|
2021
Q3 | $325K | Buy |
35,240
+974
| +3% | +$10.6K | ﹤0.01% | 4988 |
|
|
2021
Q2 | $386K | Sell |
34,266
-10,590
| -24% | -$122K | ﹤0.01% | 4911 |
|
|
2021
Q1 | $475K | Buy |
44,856
+13,470
| +43% | +$151K | ﹤0.01% | 4909 |
|
|
2020
Q4 | $340K | Buy |
31,386
+6,088
| +24% | +$62.9K | ﹤0.01% | 4885 |
|
|
2020
Q3 | $246K | Sell |
25,298
-6,722
| -21% | -$64K | ﹤0.01% | 4673 |
|
|
2020
Q2 | $254K | Buy |
32,020
+358
| +1% | +$3.69K | ﹤0.01% | 4631 |
|
|
2020
Q1 | $275K | Sell |
31,662
-12,313
| -28% | -$128K | ﹤0.01% | 4463 |
|
|
2019
Q4 | $497K | Buy |
43,975
+10,999
| +33% | +$117K | ﹤0.01% | 4842 |
|
|
2019
Q3 | $359K | Buy |
32,976
+9,780
| +42% | +$106K | ﹤0.01% | 4817 |
|
|
2019
Q2 | $218K | Buy |
23,196
+8,754
| +61% | +$88.4K | ﹤0.01% | 4871 |
|
|
2019
Q1 | $177K | Sell |
14,442
-9,144
| -39% | -$112K | ﹤0.01% | 4690 |
|
|
2018
Q4 | $280K | Sell |
23,586
-1,768
| -7% | -$24.3K | ﹤0.01% | 4682 |
|
|
2018
Q3 | $365K | Buy |
25,354
+3,301
| +15% | +$45.6K | ﹤0.01% | 4630 |
|
|
2018
Q2 | $329K | Buy |
22,053
+3,340
| +18% | +$46.4K | ﹤0.01% | 4622 |
|
|
2018
Q1 | $244K | Sell |
18,713
-1,597
| -8% | -$21K | ﹤0.01% | 4653 |
|
|
2017
Q4 | $256K | Sell |
20,310
-1,053
| -5% | -$13.3K | ﹤0.01% | 4753 |
|
|
2017
Q3 | $277K | Buy |
21,363
+1,035
| +5% | +$13.6K | ﹤0.01% | 4638 |
|
|
2017
Q2 | $302K | Buy |
20,328
+186
| +0.9% | +$2.59K | ﹤0.01% | 4482 |
|
|
2017
Q1 | $242K | Sell |
20,142
-1,338
| -6% | -$16.9K | ﹤0.01% | 4541 |
|
|
2016
Q4 | $296K | Buy |
21,480
+6,680
| +45% | +$92.5K | ﹤0.01% | 4495 |
|
|
2016
Q3 | $198K | Sell |
14,800
-3,106
| -17% | -$37.6K | ﹤0.01% | 4556 |
|
|
2016
Q2 | $192K | Buy |
17,906
+2,262
| +14% | +$25K | ﹤0.01% | 4561 |
|
|
2016
Q1 | $164K | Buy |
15,644
+1,608
| +11% | +$17.7K | ﹤0.01% | 4629 |
|
|
2015
Q4 | $166K | Buy |
14,036
+2,683
| +24% | +$32.9K | ﹤0.01% | 4812 |
|
|
2015
Q3 | $132K | Buy |
11,353
+608
| +6% | +$8.05K | ﹤0.01% | 4990 |
|
|
2015
Q2 | $155K | Hold |
10,745
| – | – | ﹤0.01% | 5085 |
|
|
2015
Q1 | $150K | Sell |
10,745
-1,295
| -11% | -$17.9K | ﹤0.01% | 5107 |
|
|
2014
Q4 | $166K | Buy |
+12,040
| New | +$156K | ﹤0.01% | 5221 |
|
Other funds holding LFCR
2L
WC
LPAM
GRIM
3C
VCM
GC
